Capula Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126K Buy
+300
New +$120K ﹤0.01% 978
2026
Q2
– Sell
-300
Closed -$106K – 739
2026
Q1
$106K Sell
300
-800
-73% -$285K ﹤0.01% 892
2025
Q4
$360K Buy
1,100
+200
+22% +$63.4K ﹤0.01% 448
2025
Q3
$254K Buy
900
+200
+29% +$58K ﹤0.01% 559
2025
Q2
$195K Sell
700
-200
-22% -$56.7K ﹤0.01% 379
2025
Q1
$280K Buy
+900
New +$266K ﹤0.01% 416
2024
Q4
– Sell
-500
Closed -$161K – 384
2024
Q3
$161K Sell
500
-500
-50% -$164K ﹤0.01% 411
2024
Q2
$312K Buy
+1,000
New +$294K ﹤0.01% 364
2023
Q4
– Sell
-14,100
Closed -$3.79M – 311
2023
Q3
$3.79M Buy
14,100
+4,800
+52% +$1.2M 0.08% 111
2023
Q2
$2.06M Sell
9,300
-163,500
-95% -$37.9M 0.05% 139
2023
Q1
$41.8M Buy
172,800
+46,300
+37% +$11.4M 0.5% 39
2022
Q4
$33.2M Sell
126,500
-3,900
-3% -$1.05M 0.45% 52
2022
Q3
$29.4M Buy
130,400
+75,100
+136% +$18.2M 0.4% 52
2022
Q2
$13.5M Sell
55,300
-719,200
-93% -$176M 0.23% 113
2022
Q1
$187M Buy
+774,500
New +$178M 2.68% 6
2021
Q4
– Sell
-17,000
Closed -$3.62M – 211
2021
Q3
$3.62M Sell
17,000
-543,000
-97% -$125M 0.04% 286
2021
Q2
$137M Buy
560,000
+414,200
+284% +$102M 2.13% 10
2021
Q1
$36.3M Buy
+145,800
New +$34.8M 0.72% 29
2020
Q4
– Sell
-19,900
Closed -$5.06M – 281
2020
Q3
$5.06M Sell
19,900
-100
-0.5% -$24.8K 0.64% 46
2020
Q2
$4.72M Buy
20,000
+15,000
+300% +$3.42M 0.17% 137
2020
Q1
$1.01M Hold
5,000
– – 0.04% 307
2019
Q4
$1.2M Buy
+5,000
New +$1.1M 0.03% 289

Other funds holding AMGN

Capula Management's AMGN Position: Q3 2026 in Review

Capula Management reduced its Amgen (AMGN) stake by 99% in Q3 2026, selling an estimated $119M and leaving 1,558 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Capula Management first reported a position in AMGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $109M in Q2 2026. 3,213 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Capula Management held 1,558 shares of Amgen worth $657K as of Q3 2026.
  • Capula Management sold 298,506 Amgen shares in Q3 2026, an estimated $119M.
  • Amgen made up ﹤0.01% of Capula Management's portfolio in Q3 2026, its #559 holding.
  • Capula Management first reported a position in Amgen in Q1 2021 and has held it in 18 quarters since.
  • Capula Management's Amgen position peaked at $109M in Q2 2026.
  • 3,213 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Capula Management's 13F filing for Q3 2026, filed 16 Nov 2026.